Orchestra BioMed Holdings, Inc. Share Price

Orchestra BioMed Holdings, Inc. Share Price

NASDAQ: OBIO | Micro Cap
$6.06
+$0.07 (1.17%) Last updated on 29 Oct, 2026 | 20:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Orchestra BioMed Holdings, Inc. Stock Performance

Open
$6.03
Prev. Close
$5.99
Circuit Range
N/A
Day Range
$6.00 - $6.05
Year Range
$3.47 - $6.45
Volume
13,555
Average Traded
$6.04

Orchestra BioMed Holdings, Inc. Share Price Today

As of 29 October 2026, Orchestra BioMed Holdings, Inc.'s share price is $6.06. The stock opened at $6.03, compared to its previous close of $5.99. During today's trading session, Orchestra BioMed Holdings, Inc.'s share price traded between $6.00 and $6.05, with an average price of $6.03. Over the past 52 weeks, the stock has recorded a high of $6.45 and a low of $3.47. In terms of performance, Orchestra BioMed Holdings, Inc.'s share price has risen by 52.07% over the last six months and is up 54.99% on a year-on-year basis.

Orchestra BioMed Holdings, Inc. Share Price Chart

Line chart of the Orchestra BioMed Holdings, Inc. price trend over the selected period. The price rose overall, ranging from 6.00 to 6.07, ending at 6.06.
$6.00$6.05
L
Show Current Price
H

Orchestra BioMed Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap
$289.35M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.99
Revenue (TTM)
$33.48B
Return On Equity (TTM)
-308.30%
Profit Margin
-158.18%
Debt to Equity
1.80
Quarterly Earnings Growth YoY
-15.60%

Orchestra BioMed Holdings, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.86$30.92$0.11$0.09
Net Profit-$20.83$5.99-$20.66-$24.08
Net Profit Margin-2422.09%19.37%-18781.82%-26755.56%
Income ChangeN/A128.76%-444.91%-16.55%

Orchestra BioMed Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$2.76$2.64$33.48
Net Profit-$49.12-$61.02-$52.96
Net Profit Margin-1779.71%-2311.36%-158.18%
Income ChangeN/A-24.23%13.21%

About Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Orchestra BioMed Holdings, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$6.25
$6.03
-3.21%
Sep 2026
$5.00
$6.22
+22.06%
Aug 2026
$4.08
$5.10
+28.63%
Jul 2026
$4.32
$3.96
-8.22%
Jun 2026
$3.90
$4.32
+11.05%
May 2026
$3.98
$3.89
-2.38%
Apr 2026
$4.43
$3.98
-6.57%
Mar 2026
$4.27
$4.26
-2.63%
Feb 2026
$3.71
$4.38
+25.14%
Jan 2026
$4.25
$3.50
-15.46%
Dec 2025
$5.29
$4.14
-22.18%
Nov 2025
$3.92
$5.32
+36.06%

OBIO Share Price FAQs